Fluarix®

BIOLOGICAL3 trials

Sponsors

GlaxoSmithKline, National Institute of Allergy and Infectious Diseases (NIAID), ModernaTX, Inc.

Conditions

Acellular PertussisDiphtheriaInfluenzaSeasonal InfluenzaTetanus

Phase 2

Influenza Vaccine in Pregnant Women

CompletedNCT00905125

National Institute of Allergy and Infectious Diseases (NIAID)Influenza

Start: 2009-06-30End: 2010-03-31Updated: 2012-06-13

Phase 3

Immunogenicity, Safety of GSKs Tdap Vaccine Boostrix When Coadministered With GSKs Influenza Vaccine Fluarix in Adults

CompletedNCT00385255

GlaxoSmithKlineAcellular Pertussis, Diphtheria, Tetanus

Start: 2006-10-23End: 2007-02-28Updated: 2019-06-10

A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age

CompletedNCT06602024

ModernaTX, Inc.Seasonal Influenza

Start: 2024-09-16End: 2025-08-21Updated: 2025-09-10

Related Papers

229. mRNA-1010, an mRNA-Based Influenza Vaccine, is Safe and Efficacious in Adults Aged ≥50 Years

Open Forum Infectious Diseases2026-01-01

An mRNA-based seasonal influenza vaccine in adults: Results of two phase 3 randomized clinical trials and correlate of protection analysis of hemagglutination inhibition titers

Human Vaccines & Immunotherapeutics2025-04-0213 citations